- Global Pharma News & Resources

Vitamin D Market Analysis and Forthcoming Strategies For Business 2019 to 2028

Vitamin D is a steroid vitamin that promotes intestinal absorption and metabolism of calcium and phosphorus. Under normal conditions of sunlight exposure, no dietary supplementation is necessary because sunlight promotes adequate vitamin D synthesis in the skin. Vitamin D deficiency can lead to bone deformity (rickets) in children and bone weakness in adults. It is required for normal growth and development of bones and teeth, protects against muscle weakness, and regulates heart functions. Vitamin D is consumed in food and is present in eggs, fish, and dairy products and is also produced in human skin. Skin production of the active form of vitamin D depends on exposure to sunlight, and the skin is more capable of producing it during the initial part of the day. Active people living in sunny regions produce most of the vitamin D their skin needs.

To get more insights, visit:

Incidences of diseases caused by vitamin D deficiency such as rickets have been increasing in some developing and also underdeveloped countries around the world. Rickets is a skeletal disorder caused by lack of vitamin D, calcium, or phosphate. Increasing cases of child malnourishment, which is a condition that results from consuming foods that lack sufficient nutrients and causes health problems. Increasing incidence of osteoporosis and osteomalacia in various countries across the globe is a major factor driving demand for vitamin D and related products.

However, regulatory standards in some countries to prevent vitamin D toxicity is a factor restraining growth of the market.

Segmentation on the basis of analog type:

  • Vitamin D2
  • Vitamin D3

Segmentation on the basis of application type:

  • Functional food & beverages
  • Pharmaceuticals
  • Animal feed & pet food
  • Personal care

Segmentation of the basis of End User type:

  • Children
  • Adults
  • Pregnant Women

Get Free Sample Copy Of This Research @

North America dominated the global market, accounting for around of the total market revenue in 2016. Development in emerging markets such as Brazil, Italy, India, and China is paving way for new and lucrative opportunities for growth of this market.

Key players in the global biosimilars market include Abbott Laboratories, Archer Daniels Midland Company, BASF SE, Fermenta Biotech Ltd., Groupe Danone SA, Koninklijke Dsm NV, Kraft Foods Group, Inc., Nestle SA, Pfizer, Inc., and Synthesia, AS.

Editor Details

Last Updated: 21-Feb-2019